UPDATE: Mirati Therapeutics (MRTX) PT Lowered to $105 at Oppenheimer
Tweet Send to a Friend
(Updated - May 5, 2022 5:15 PM EDT)
Oppenheimer analyst Jay Olson lowered the price target on Mirati Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson lowered the price target on Mirati Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
